Stonegate Capital Partners has updated its coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) following the company's first-quarter 2026 earnings release, which fell short of expectations due to timing issues in Canada and select international projects. However, continued momentum in the U.S. market helped offset the shortfall, preserving the core investment thesis.
According to Stonegate's analysis, the quarter does not change the fundamental outlook centered on U.S. product momentum, ResMetrics integration, and the company's capital-light business model. Instead, it highlights the timing risk associated with Canada seasonality and project-based international work. The key change is the cadence of earnings, with second-quarter guidance implying a softer near-term trough, while full-year 2026 Adjusted EBITDA guidance remains unchanged, pointing to a back-half-weighted recovery driven by deferred Canadian work, recurring activity from Repeat Precision, and synergies from ResMetrics.
Management also noted that the 2026 guidance excludes potential sliding sleeve deliveries for its first deepwater Gulf of Mexico opportunity, which could materialize in late 2026 or early 2027. This represents a potential upside catalyst that is not yet reflected in current forecasts.
Key takeaways from the update include: first-quarter results missed on Canada and international timing, but U.S. revenue more than doubled, preserving the thesis. The full-year EBITDA guidance was maintained, shifting focus to a second-half recovery and execution from Repeat Precision. Additionally, positive free cash flow and $53 million in liquidity support the integration of ResMetrics, capacity expansion, and growth investments.
For more details, the full announcement is available here.
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Its affiliate, Stonegate Capital Markets (member FINRA), offers a full spectrum of investment banking, equity research, and capital raising for public and private companies.
